Skip to main content
Classification of current anticancer immunotherapies
Published Web Location
http://europepmc.org/articles/PMC4350348?pdf=renderNo data is associated with this publication.
Abstract
During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency for us
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.